Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study

Many people with sickle cell disease (SCD) or other anemias require chronic blood transfusions, which often causes iron overload that requires chelation therapy. The iron chelator deferiprone is frequently used in individuals with thalassemia syndromes, but data in patients with SCD are limited. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwiatkowski, Janet L., Hamdy, Mona, El-Beshlawy, Amal, Ebeid, Fatma S. E., Badr, Mohammed, Alshehri, Abdulrahman, Kanter, Julie, Inusa, Baba, Adly, Amira A. M., Williams, Suzan, Kilinc, Yurdanur, Lee, David, Tricta, Fernando, Elalfy, Mohsen S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864642/
https://www.ncbi.nlm.nih.gov/pubmed/34847228
http://dx.doi.org/10.1182/bloodadvances.2021004938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864642/
https://www.ncbi.nlm.nih.gov/pubmed/34847228
http://dx.doi.org/10.1182/bloodadvances.2021004938

Ejemplares similares